HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients.

Abstract
Thymidine Pi deoxyribosyltransferase (TP) is an enzyme involved in DNA synthesis up-regulated in tumours and it is also a pro-angiogenic factor. TP cannot activate capecitabine, because capecitabine first needs conversion by carboxylesterase and cytidine deaminase into 5-deoxy-fluorouridine. This compound can be activated by TP to 5-fluorouracil (5-FU). Although TP is not necessary for 5-FU toxicity, experimental data suggest that high levels of TP correlate with an enhanced response to 5-FU therapy. In this study, we have analysed by immunohistochemistry CD34, CD68 and TP positive cells in bioptic samples from 53 patients with T(1-3) N(0-1) M(0) oropharyngeal squamous cell carcinoma (OSC) and from 24 patients with non-dysplastic oropharyngeal leukoplakia (NDOLP). Results showed that the mean of TP-positive cells, CD68 positive macrophages and CD34 positive endothelial cells eval-uated as microvessel density (MVD) was significantly higher in OSC than in NDOLP. Moreover, at a median follow-up of 19 months, patients with TP expression and higher MVD showed a better survival rate as compared to those with low MVD, probably as a consequence of 5-FU-based therapy.We hypothesized a role for TP in oropharyngeal tumourigenesis and 5-FU activation in the adjuvant setting of OSC patients.
AuthorsG Ranieri, L Grammatica, R Patruno, A F Zito, P Valerio, S Iacobellis, C Gadaleta, G Gasparini, D Ribatti
JournalJournal of cellular and molecular medicine (J Cell Mol Med) 2007 Mar-Apr Vol. 11 Issue 2 Pg. 362-8 ISSN: 1582-1838 [Print] England
PMID17378915 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Thymidine Phosphorylase
  • Fluorouracil
Topics
  • Age Distribution
  • Aged
  • Carcinoma, Squamous Cell (drug therapy, metabolism, pathology)
  • Case-Control Studies
  • Female
  • Fluorouracil (therapeutic use)
  • Humans
  • Immunohistochemistry
  • Leukoplakia (pathology)
  • Male
  • Oropharyngeal Neoplasms (drug therapy, metabolism, pathology)
  • Thymidine Phosphorylase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: